MODIFICATION TO: PLEXALONG SETS
K-Number: K042979 · 2004-12-21
Advertisement
Device Summary
Frequently Asked Questions
What is the MODIFICATION TO: PLEXALONG SETS?
MODIFICATION TO: PLEXALONG SETS is a medical device that received FDA 510(k) clearance on 2004-12-21. The listed applicant is Pajunk GmbH. The 510(k) number is K042979.
When did MODIFICATION TO: PLEXALONG SETS receive FDA 510(k) clearance?
MODIFICATION TO: PLEXALONG SETS received FDA 510(k) clearance on 2004-12-21, under 510(k) number K042979.
Who is the listed applicant for MODIFICATION TO: PLEXALONG SETS?
The FDA 510(k) record lists Pajunk GmbH as the applicant. This does not by itself establish the device manufacturer.
What is the FDA product code for MODIFICATION TO: PLEXALONG SETS?
The FDA product code for MODIFICATION TO: PLEXALONG SETS is BSP.
Related Clinical Trials
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Other records listing Pajunk GmbH as applicant
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Related Devices (Code: BSP)
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Official Source
View on FDA Database →Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.
Advertisement